Australia markets closed

AFT Pharmaceuticals Limited (AFP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
4.2000-0.0100 (-0.24%)
At close: 03:16PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 453.95M
Enterprise value 488.79M
Trailing P/E 42.99
Forward P/E 19.42
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.87
Price/book (mrq)11.37
Enterprise value/revenue 4.08
Enterprise value/EBITDA 31.19

Trading information

Stock price history

Beta (5Y monthly) 0.08
52-week change 3-1.64%
S&P500 52-week change 327.77%
52-week high 35.1300
52-week low 33.6400
50-day moving average 34.2162
200-day moving average 34.1747

Share statistics

Avg vol (3-month) 31.45k
Avg vol (10-day) 35.43k
Shares outstanding 5104.69M
Implied shares outstanding 6N/A
Float 828.34M
% held by insiders 173.29%
% held by institutions 18.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2021
Most-recent quarter (mrq)30 Sept 2021


Profit margin 9.04%
Operating margin (ttm)11.50%

Management effectiveness

Return on assets (ttm)8.62%
Return on equity (ttm)30.52%

Income statement

Revenue (ttm)119.8M
Revenue per share (ttm)1.24
Quarterly revenue growth (yoy)13.70%
Gross profit (ttm)48.74M
Net income avi to common (ttm)10.64M
Diluted EPS (ttm)0.1020
Quarterly earnings growth (yoy)256.00%

Balance sheet

Total cash (mrq)5.91M
Total cash per share (mrq)0.06
Total debt (mrq)42.07M
Total debt/equity (mrq)102.36
Current ratio (mrq)2.60
Book value per share (mrq)0.39

Cash flow statement

Operating cash flow (ttm)10.32M
Levered free cash flow (ttm)-2.16M